Based on the Shanghai Fosun Pharmaceutical (Group) Co. Ltd stock forecast from 0 analysts, the average analyst target price for Shanghai Fosun Pharmaceutical (Group) Co. Ltd is not available over the next 12 months. Shanghai Fosun Pharmaceutical (Group) Co. Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Shanghai Fosun Pharmaceutical (Group) Co. Ltd is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, Shanghai Fosun Pharmaceutical (Group) Co. Ltd’s stock price was USD 1.55. Shanghai Fosun Pharmaceutical (Group) Co. Ltd’s stock price has changed by +1.17% over the past week, -7.60% over the past month and -45.71% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for SFOSF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
